Loading clinical trials...
Loading clinical trials...
Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients Undergoing Mechanical Ventilation: a Randomized Controlled Trial
Sedation and analgesia are fundamental tools for managing critical patients who require mechanical ventilation. However, recent scientific literature highlights that excessive sedation in these patients can increase the duration of mechanical ventilation and extend the overall length of stay in intensive care, as well as expose them to a higher risk of hypotension, venous thrombosis, and nosocomial pneumonia. The titration of sedation and analgesia in intensive care, on the other hand, is currently based primarily on clinical parameters (such as the onset of delirium, asynchronies with the ventilator, for example), which can lead to treatments not proportionate to the patient's needs. The present study aims to evaluate the application, in an intensive care setting, of the Conox® system, a device already widely used in monitoring the anesthetic plan in the operating room. This tool would allow, through the processing of an EEG trace, the assessment of the level of sedation (qCON) and the probable algic response (qNOX), thus providing valuable information for the fine-tuning of the analgo-sedative plan.
Age
18 - 90 years
Sex
ALL
Healthy Volunteers
No
Azienda Ospedaliera Universitaria Sant'Anna
Ferrara, Italy, Italy
Azienda Ospedaliera Universitaria Federico II - "Policlinico"
Naples, Napoli, Italy
Start Date
January 1, 2024
Primary Completion Date
December 31, 2026
Completion Date
July 31, 2027
Last Updated
January 10, 2025
174
ESTIMATED participants
Sedation titration according to qEEG
DEVICE
Sedation titration according to standard of care
PROCEDURE
Lead Sponsor
Università degli Studi di Ferrara
Collaborators
NCT07207772
NCT06971042
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions